HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Sandra Aung, Ph.D. OncoSec’s New Senior VP, and Chief Clinical Development Officer: Provides 20 Plus Years of Pharma and Biotech Experience
Dr. Aung will be responsible for overseeing KEYNOTE-695, the Company's Phase 2b trial.
Pam Shang Appointed VP of Global Quality at Crown Bioscience
Shang will be instrumental in further enhancing global quality across the company, leveraging her deep expertise in implementing quality systems for pharma and biotechnology clients including in GLP, GMP and other regulated environments.
Michael McNeil Added to BOD of MedCrypt – Expert Offers 35 Years of Strong Cybersecurity Experience
McNeil brings experience from Royal Philips and Medtronic to the proactive medical device cybersecurity provider.
CMR Surgical appoints Bill McComb as Non-Executive Director
Bill McComb brings medical devices expertise alongside diverse leadership experience including branding and digital and will work with the management team to support CMR’s expanding commercial activities.
Paul Estrem CFO of NorthStar Medical Technologies Promoted to EVP and Appointment to Board of Managers
Paul Estrem has more than 30 years of relevant financial experience in the life science and medical technology industries.
Chris Wolff Is Appointed VP of U.S. Sales at BioVentrix – Offers 20 Plus Years of Cardiac Industry Experience
Wolff will be responsible for driving enrollment in the ongoing ALIVE Trial studying the Company’s Revivent TC™ Transcatheter Ventricular Enhancement System, which has reimbursement from the Centers for Medicare and Medicaid Services
Debbie Thurmond Named New Director of City of Hope’s Diabetes & Metabolism Research Institute
“I am absolutely delighted and humbled to be named director of City of Hope's DMRI," said Debbie Thurmond, Ruth B. & Robert K. Lanman Chair in Gene Regulation & Drug Discovery Research. “Art has built a phenomenal institute, and I have the great pleasure of facilitating its continued growth and prominence in the diabetes space.”
Cyted Appoints Martin Frost as Commercial and Strategic Advisor
Frost will guide the Cyted team as the Company continues to grow and commercialise its products and services offering.
Allan May Has Been Appointed Chairman of FundamentalVR – Respected and Established Figure in Silicon Valley
September 23, 2020
Allan May has been appointed Chairman of FundamentalVR. The news was announced today.
Allan May is a renowned Medtech pioneer. May will lead...
